Kalata B1
General Information
DRACP ID DRACP00296
Peptide Name Kalata B1
Sequence GLPVCGETCVGGTCNTPGCTCSWPVCTRN
Sequence Length 29
UniProt ID Not available
PubChem CID Not available
Origin Oldenlandia affinis; Viola yedoensis; Viola odorata; Viola baoshanensis
Type Native peptide
Classification
Active ACP
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
MM96L | Melanoma | Carcinoma | IC50=3.10±0.06µM | MTT assay | 5h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=10.21±0.43µM | MTT assay | 5h | 1 |
BGC-823 | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=1.32±0.15µM | SRB assay | 48h | 1 |
U-937/GTB | Adult acute monocytic leukemia; Acute monoblastic/monocytic leukemia | Leukemia | IC50=6.9µM | FMCA assay | 72h | 2 |
K562 | Blast phase chronic myelogenous leukemia, BCR-ABL2 positive; Chronic myeloid leukemia | Leukemia | 50% Cell death=13.1±0.4µM | Resazurin assay | 2, 24h | 3 |
Hemolytic Activity Human erythrocytes: Human erythrocytes: 41% Hemolysis=25 µM; Human erythrocytes: 50% Hemolysis=29.1±1.1 µM
Normal (non-cancerous) Cytotoxicity HFF-1: IC50=2.38±0.09 µM; 50% Cell death=12.0±0.5 µM; CEM-SS cells: IC50=5.7 µM; Human PBMC: 50% Cell death=11.2±0.5 µM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer; Antibacterial; Antifungal; Antiviral
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond Cys5<--->Cys19; Cys9<--->Cys21; Cys14<--->Cys26; NCB: Gly1<--->Asn29
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C117H187N35O40S6
Absent amino acids ADFHIKMQY
Common amino acids C
Mass 341596
Pl 5.94
Basic residues 1
Acidic residues 1
Hydrophobic residues 5
Net charge 0
Boman Index -1951
Hydrophobicity 15.17
Aliphatic Index 43.45
Half Life
Mammalian: 30 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 5875
Absorbance 280nm 209.82
Polar residues 19
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 21723349
Title Isolation and characterization of cytotoxic cyclotides from Viola philippica
Doi 10.1016/j.peptides.2011.06.016
Year 2011
Literature 2
Pubmed ID 28669767
Title Bactericidal activity of cyclotides where phosphatidylethanolamine-lipid selectivity determines antimicrobial spectra
Doi 10.1016/j.bbamem.2017.06.018
Year 2017
Literature 3
Pubmed ID 25099014
Title Anticancer and toxic properties of cyclotides are dependent on phosphatidylethanolamine phospholipid targeting
Year 2014
Literature 4
Pubmed ID 21576247
Title Decoding the membrane activity of the cyclotide kalata B1: the importance of phosphatidylethanolamine phospholipids and lipid organization on hemolytic and anti-HIV activities
Year 2011
Literature 5
Pubmed ID 18081258
Title Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis
Year 2008
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available